期刊文献+

肥大细胞糜蛋白酶在瘢痕疙瘩组织的活性表达

The expression of mast cells chymase activity in keloid tissue
暂未订购
导出
摘要 目的探讨肥大细胞糜蛋白酶在人瘢痕疙瘩组织中的表达活性。方法采用免疫组织化学法检测瘢痕疙瘩组织和正常皮肤中肥大细胞的数量和糜蛋白酶的表达,并以RT-PCR和放免法检测瘢痕疙瘩和正常皮肤组织中糜蛋白酶mRNA表达活性变化。结果瘢痕疙瘩组织中肥大细胞数量与糜蛋白酶阳性表达评分为(10±0.25)个/HP、(6.2±0.23)mm2,明显高于正常皮肤组织的(4±0.22)个/HP、(2.5±0.12)mm2(P<0.01);RT-PCR结果显示瘢痕疙瘩组织中肥大细胞mRNA和糜蛋白酶mRNA表达水平较正常皮肤组织明显增高。结论肥大细胞糜蛋白酶存在于瘢痕疙瘩中且活性表达明显高于正常皮肤组织。 Objective To explore the expressed activity of mast cells chymase exist in human keloid tissues. Methods The number of mast cell and chymase expression in keloid and normal skin were assessed by im- munohistochemieal methods. Quantitative real-time PCR and Radio immunity method were conducted to measure the change of mRNA expressed activity of chymase in keloid and normal skin tissues. Results Com- pared with normal skin tissue, the number of mast cells and chymase expression were higher in keloid tissues [ (10 ±0.25)/hp vs (4±0.22)/hp, and (6.2±0.23) mm^2 vs (2.5±0.12) mm^2 , P 〈0.01)]. The results of RT-PCR showed mast cell mRNA expression levels and chymase mRNA level were also significantly higher in keloid tissues than those of normal skin tissues (P 〈0.05). Conclusion The chymase of mast cells exists in keloids and the expressed activity of chymase is statistically higher than those of normal skin tissues.
作者 徐涛 董祥林
出处 《新疆医科大学学报》 CAS 2015年第3期302-305,309,共5页 Journal of Xinjiang Medical University
基金 新疆医科大学第一附属医院青年科研基金(2012QN02)
关键词 肥大细胞糜蛋白酶 瘢痕疙瘩 活性表达 keloid mast cells chymase activity
  • 相关文献

参考文献5

二级参考文献47

  • 1向军,王志勇,贾生贤,金曙雯,陆树良,廖镇江.一种增生性瘢痕动物模型的建立[J].中华烧伤杂志,2004,20(5):281-283. 被引量:11
  • 2周勤生,马少林,董祥林.兔耳增生性瘢痕动物模型的建立与应用[J].新疆医科大学学报,2005,28(8):746-748. 被引量:5
  • 3李虎,李小静,宁金龙,高凤山,董继英,杨小奇,陈敏.兔耳增生性瘢痕模型的建立及微血管构筑在病理性瘢痕形成和发展过程中的意义[J].中国临床康复,2006,10(4):116-118. 被引量:15
  • 4郭丽丽,刘林嶓,陈言汤.MMP-1、TIMP-1及PDGF在病理性瘢痕中的表达[J].中国美容整形外科杂志,2006,17(5):340-342. 被引量:9
  • 5Bettinger DA, Pellicane JV, Tarry WC, et al. The role of inflammatory cytokines in wound healing: Accelerated healing in endotoxin resistant mice. J Trauma, 1994, 36(6):810-813.
  • 6Casiagnoli C, Stella M, Berthod C, et al. TNF production and hypertrophic scarring. Cell Immunol, 1993,147 ( 1 ):5 -63.
  • 7Brown GL, Curtsinger IJ, White M, et al. Acceleration of tensile strength of incisions treated with EGF and TGF-β. Ann Surg, 1988,208(6):788-791.
  • 8Irani AM, Gruber BL, Kaufman LD, et al. Mast cell changes in scleroderma: Prescence of MCT cells in the skin and evidence of mast cell activation. Arthritis Rheum, 1992,35(8):933-939.
  • 9Heard BE, Dewar A, Corrin B. Apposition of fibroblasts to mast cells and lymphocytes in normal human lung and in cyptogenic fibrosing alveolitis: ultrastructure cell perimeter measurement. J Pathol, 1992,166(3):303-310.
  • 10Takeda K, Hatamochi A, Ueki H. Increased number of mast cells accompany enhanced collagen synthesis in linear localized scleroderma. Arob Dermatol Res, 1989,281(4):288-290.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部